Taxi and ambulance drivers are less likely than workers in almost any other job to die of Alzheimer's disease.

Deborah Kan, founder of "Being Patient," established the platform after her mother's Alzheimer's diagnosis to bridge critical ...

Oshkosh’s Walk to End Alzheimer’s is Sept. 26 at Lakeshore Pavilion, raising funds for care, support and research.

"Based on your evaluation, I’ve reviewed the memory tests you took, and we believe Alzheimer's disease is causing your symptoms. We'd like to see you back in six months.” As they sat in the parking ...

A new study presents the first complete T2T marmoset genome, advancing Alzheimer's research and primate genomics.

A new study reveals how hyperphosphorylated tau causes reverse electron transport in mitochondria, driving Alzheimer's ...

One of the hallmarks of Alzheimer's disease is the accumulation of a peptide in the brain known as amyloid beta. A new study ...

Australia has approved donanemab (Kisunla), the first new Alzheimer's treatment in 25 years, capable of slowing disease ...

Kisunla is designed to help slow the progression of early symptomatic Alzheimer's by targeting the brain to break up and ...

The U.S. Food and Drug Administration (FDA) recently approved a subcutaneous starter dose of Leqembi, a drug indicated to treat mild cases of Alzheimer’s disease. With the new approval, people can use ...